Healthcare

The closings were 'a significant accomplishment, given the persistent industry headwinds in private equity fundraising', CEO Jon Winkelried says.

The firm’s exit activity slumped around 45% in 2023 as IPO window remained largely shut.

EQT Healthcare Growth will back businesses that have de-risked from a scientific point of view and are at a pivotal stage of development, EQT's healthcare co-head tells PEI.

GP stakes, healthcare and Middle Eastern investors will be front of mind for Asia-Pacific markets in 2024.

Increased consumption and pervasive budgetary constraints are continuing to drive investment and innovation in the healthcare industry.

Innovative strategies from the private sector are required to deliver strong health outcomes for patients across socio-demographics.

Asian healthcare specialist CBC Group believes specialised debt funds focused on pharma products can be complementary to equity investments.

Private equity has an important role to play in the US healthcare system’s transition from a fee-for-service model to a system based on outcomes, believe Ravi Sachdev, Ron Williams and Keith Pitts at Clayton, Dubilier & Rice.

The Singapore-headquartered multifamily office has gathered more than $1bn in AUM within six months of launching and is on the hunt for new GP relationships.

PE interest in healthcare is in good shape despite suffering some macroeconomic side effects.